In case of its positivity, WT1 can be used a surrogate marker to differentiate astrocytic tumors notably grade II diffuse astrocytoma from astrogliosis with high accuracy, but is of no value in case of negativity. This evidence concerns the gene WT1 and diffuse astrocytoma.